Amarin Corp. Plc (AMRN)
13.94
-0.10
(-0.71%)
USD |
NASDAQ |
Dec 30, 11:12
Amarin EPS Diluted (Quarterly): -0.3702 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Trinity Biotech Plc | -0.3242 |
| Jazz Pharmaceuticals Plc | 4.081 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.692M |
| Revenue (Quarterly) | 49.37M |
| Total Expenses (Quarterly) | 57.06M |
| Enterprise Value | 11.77M |
| Gross Profit Margin (Quarterly) | 42.97% |
| Profit Margin (Quarterly) | -15.58% |
| Earnings Yield | -29.88% |
| Normalized Earnings Yield | -22.04 |